Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
it-hMSC in Ischemic Stroke
NCT04590118Phase 2Unknown
- Sponsor
- Jiuzhitang Co., Ltd.
- Start
- Apr 2021
- Primary completion
- Apr 2023
- Modality
- Mesenchymal Stem Cells
- Countries
- 1
01
Overview
A Phase 2 trial of human bone marrow mesenchymal stem cell injection in ischemic stroke, sponsored by Jiuzhitang Co., Ltd.. Status: unknown.
02
Drugs
human bone marrow mesenchymal stem cell injection
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT04590118.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04590118.